Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Recombinant Clonorchis sinensis heat shock cognate protein B patented by Xuzhou Medical University

Oct. 15, 2019

GalNAc-siTAZ improves hepatic inflammation, fibrosis and liver damage in models of NASH

Oct. 15, 2019

RedHill reports full data from phase III MAP US study of RHB-104 in Crohn's disease

Oct. 14, 2019

Yuhan identifies AOC3 inhibitors

Oct. 11, 2019

NGM reports promising interim results from ongoing phase II study of aldafermin in NASH

Oct. 9, 2019

Prometheus Biosciences and Takeda collaborate to develop novel IBD therapies

Oct. 4, 2019

Biomica begins preclinical studies with microbial consortia BMC-321 and BMC-322 for IBD

Oct. 3, 2019

Knockdown of Fas death receptor shows hepatoprotective effect against NASH in mice

Oct. 2, 2019

Galmed initiates phase III/IV study of aramchol in patients with NASH and fibrosis

Sep. 27, 2019

New TYK2 inhibitors detailed in AbbVie patent

Sep. 27, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...